C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/2006
10/24/2006	US7125955 mitotic kinase, NIMA, encoded by the Aspergillus nimA gene; pure WW domain of a Pin1 polypeptide which interacts with NIMA; a Peptidyl-prolyl cis/trans isomerases (PPIase); drug target; Pin1 is a PPIase known to be essential for life
10/24/2006	US7125872 protease/thrombin inhibitors
10/24/2006	US7125847 polypeptides isolated from spider venoms, used as antiarrhythmia agents; cardiovascular disorders
10/24/2006	US7125843 Glycoconjugates including more than one peptide
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125837 Elastin-based compositions
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125669 Solid-phase immobilization of proteins and peptides
10/24/2006	US7125569 Removal of plasmin(ogen) from protein solutions
10/19/2006	WO2006110644A2 Improved methods and devices for concentration and fractionation of analytes for chemical analysis including matrix-assisted laser desorption/ionization (maldi) mass spectrometry (ms)
10/19/2006	WO2006110277A1 Protein purification using hcic amd ion exchange chromatography
10/19/2006	WO2006109599A1 Antibody reactive specifically to age derived from 3,4-dge
10/19/2006	WO2006108826A1 Basic protein purification tags from thermophilic bacteria
10/19/2006	WO2006108594A1 Peptide synthesis of alpha-helixes on peg resin
10/19/2006	WO2006089245A3 Bubble architectures and methods of making and using thereof
10/19/2006	WO2006084130A9 Ultra-sensitive detection systems using multidimension signals
10/19/2006	WO2006066078A3 Fcϝriib-specific antibodies and methods of use thereof
10/19/2006	WO2004084810A3 Novel imidazoline receptor homologs
10/19/2006	WO2004074302A3 Autosomal recessive polycystic kidney disease nucleic acids and peptides
10/19/2006	US20060236433 Nicotiana hybrids and plant varieties for use in production of pharmaceuticals
10/19/2006	US20060234385 Polyglutamine repeat sequences
10/19/2006	US20060234291 Site selective acylation
10/19/2006	US20060234255 Novel proteins and nucleic acids encoding same
10/19/2006	US20060234226 Non-affinity purification of proteins
10/19/2006	US20060233747 Polymer-modified synthetic proteins
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060231401 Image display panel manufacturing method, image display device manufacturing method, and image disiplay device
10/19/2006	US20060231399 Single-wall carbon nanotube compositions
10/19/2006	US20060231398 Microfluidic method and device for transferring mass between two immiscible phases
10/19/2006	CA2604877A1 Protein purification
10/19/2006	CA2600291A1 Peptide synthesis of alpha-helixes on peg resin
10/18/2006	EP1712623A2 Selection of proteins using RNA-protein fusions
10/18/2006	EP1712558A1 Method for separating/refining cationic protein
10/18/2006	EP1711513A2 Nanofiltration of factor vii solutions to remove virus
10/18/2006	EP1711512A1 Process for purifying proteins
10/18/2006	EP1711511A1 Method for crystallization of proteins using polysaccharides
10/18/2006	EP1578768A4 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
10/18/2006	EP1397686B1 Method for characterizing polypeptides
10/18/2006	EP1104479B1 Method for recovering proteins from the interstitial fluid of plant tissues
10/18/2006	CN1849332A REPLIKIN peptides and uses thereof
10/18/2006	CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor
10/18/2006	CN1847260A Wheat germ protein depressor peptide desalting process
10/18/2006	CN1847259A Preparation of a therapeutic composition
10/18/2006	CN1280309C Erythropoietin with high specific activity
10/18/2006	CN1280308C Production of polysaccharide peptide
10/18/2006	CN1280306C Method for purifying Sa antigen
10/17/2006	US7122703 Chemoselective ligation
10/17/2006	US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli
10/17/2006	US7122654 Hybrid; adjust vascular system permeability
10/17/2006	US7122642 Inducing the nucleation of selected crystal polymorphs from supersaturated solutions by using laser light to induce nucleation
10/17/2006	US7122641 Methods for purifying protein
10/17/2006	US7122640 Using solid phase extraction in an open channel device to recover/isolate biomolecules or biomolecule complexes, such as, polypeptides, polynucleotides, and/or polysaccharides
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII
10/17/2006	US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006	US7122628 Process for the synthesis of a peptide having a Trp residue
10/17/2006	US7122382 Synthesizing a protein having a label for detection and another protein having a modification for separation in a single system by the cell-free protein synthesis; separating a pair of proteins formed by the interaction between these proteins
10/17/2006	US7122381 Selective affinity material, preparation thereof by molecular imprinting, and use of the same
10/17/2006	US7122361 Compositions employing a novel human kinase
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122358 Testis-specific tubulin tyrosine-ligase-like protein, BGS42
10/17/2006	US7122354 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122324 Vitro methods for determining in vivo thrombotic events
10/17/2006	US7122321 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
10/17/2006	CA2342141C Method for detection of legionella bacteria employing purified antigen-specific antibodies
10/12/2006	WO2006107982A2 Methods and precipitating reagents for isolating proteins from proteinaceous material
10/12/2006	WO2006107963A2 Process for preparing dipeptide amides
10/12/2006	WO2006106903A1 sc(Fv)2 STRUCTURAL ISOMERS
10/12/2006	WO2006105985A1 Reversible sequential binding assays
10/12/2006	WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006	WO2006105653A1 Method and system for identification of antigen
10/12/2006	WO2005117954A3 Compositions and methods for treatment of neovascular diseases
10/12/2006	WO2005042561A3 Neural regeneration peptides and methods of use
10/12/2006	WO2004058088A3 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries
10/12/2006	US20060229437 Process for purifying proteins
10/12/2006	US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides
10/12/2006	US20060229246 Peptide-enhanced transfections
10/12/2006	US20060228359 antibody; host cell; hybridoma;
10/12/2006	US20060228326 Active specific immunotherapy of cancer metastasis
10/12/2006	DE4237113B4 Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins Peptides and fusion proteins, expression vector and methods for producing a fusion protein
10/12/2006	CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
10/12/2006	CA2603936A1 Protein glycosylation
10/12/2006	CA2603551A1 High resolution methods and precipitating reagents for isolating proteins from proteinaceous material
10/12/2006	CA2602615A1 Method and system for identification of antigen
10/11/2006	EP1710250A1 Method for preparing serum albumin through heat-treatment in presence of divalent cation
10/11/2006	EP1709435A1 Methods, devices and systems for characterizing proteins
10/11/2006	EP1709421A1 Methods for diagnosis and pronosis of cancers of epithelial origin
10/11/2006	EP1709065A2 A counterion exchange process for peptides
10/11/2006	EP1708755A2 Transglutaminase mediated conjugation of peptides
10/11/2006	EP1509300B1 Production of crystalline materials by using high intensity ultrasound
10/11/2006	EP1504022B1 Process for the synthesis of peptide amides by side-chain attachment to a solid phase
10/11/2006	EP1469741B1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
10/11/2006	EP1390485B1 Removal of plasmin(ogen) from protein solutions
10/11/2006	EP1343391B1 METHOD FOR MODIFYING THE PROTEIN STRUCTURE OF PRIONS PRPsc IN A TARGETED MANNER
10/11/2006	EP1257829B1 Complementation assay assessing protein solubility and folding
10/11/2006	EP1154827B1 Purification of biological substances
10/11/2006	EP1066522B1 Pharmacophore recombination for the identification of small molecule drug lead compounds
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/11/2006	CN1845989A Recombinant production of antimicrobial agents

1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 518